Resultado de búsqueda
Hace 23 horas · In light of HOOKIPA Pharma Inc.'s recent announcement of a reverse stock split, investors are closely monitoring the company's financial metrics and market performance. According to InvestingPro data, HOOKIPA's market capitalization stands at $55.91 million, with a striking revenue growth of 235.12% over the last twelve months as of Q1 2024.
Hace 2 horas · About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. HOOKIPA’s replicating and non-replicating ...
Hace 23 horas · HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to ...
Hace 23 horas · HOOKIPA Pharma è un'azienda in fase di sviluppo clinico che sviluppa nuove immunoterapie utilizzando la sua piattaforma proprietaria di arenavirus, per combattere gravi malattie amplificando le risposte delle cellule T mirate. La sua pipeline comprende terapie per i tumori positivi al Papillomavirus umano 16 e per i tumori mutati in KRAS, tra ...
Hace 23 horas · NEW YORK - HOOKIPA Pharma Inc. (NASDAQ:HOOK), a biopharmaceutical company specializing in immunotherapeutics, today announced a 1-for-10 reverse stock split of its common stock, set to take effect after market close on Tuesday.The move is aimed at regaining compliance with Nasdaq's minimum bid price requirement. Starting Wednesday, HOOKIPA's common stock will trade on the Nasdaq Capital Market ...
Hace 12 horas · About HOOKIPA. HOOKIPA Pharma Inc. HOOK is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. HOOKIPA’s replicating and non-replicating technologies are ...
Hace 12 horas · HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to ...
